A large cohort-study carried out by Chen et al. showed that ANXA4 expression was significantly up-regulated in HCC tumor with early recurrence/metastasis and correlated with both the clinicopathologic characteristics and the poor overall survival of HCC patients. This evidence concerns the gene ANXA4 and hepatocellular carcinoma.